Navigation Links
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Date:8/20/2007

tial thrombosis increases the relative risk of death by five- to ten-fold for PNH patients.(3,7) Thrombosis is related to hemolysis in patients with PNH, and patients with both smaller and larger PNH clones are reported to experience this complication.(8,9,10,11,12) Research involving a small group of PNH patients, including those without a history of blood transfusion, found that 60 percent had sub-clinical thrombosis, which could later develop into blood clots.(13)

"For decades, people with PNH have lived with debilitating symptoms, including the threat of blood clots and their complications," said Leonard Bell, MD, Chief Executive Officer of Alexion. "This publication reinforces the importance of our goal to ensure that every PNH patient who can benefit from Soliris will have access to it."

"Many PNH patients face not only devastating symptoms, but a sharply increased risk for developing life-threatening blood clots as a result of their disease," said John Huber, Executive Director of the Aplastic Anemia & MDS International Foundation. "This news provides additional hope for patients struggling with PNH and the danger of PNH-related blood clots. We look forward to seeing the impact this new analysis has on treatment of patients with PNH."

Clinical Data

The publication, titled "Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria," analyzed data from 195 patients studied in the Soliris Phase II and Phase III trials, including the TRIUMPH and SHEPHERD studies. Patients were enrolled in the United States, Europe, Australia and Canada and treated with Soliris for up to 54 months. Soliris reduced hemolysis in all treated patients and reduced thrombosis by 92 percent, with three events during Soliris treatment compared to 39 events during the same period of time prior to treatment (P<0.0001). The collection of thrombotic events was defined prospectively by clinical trial protocols.
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method
2. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
3. What patients want: A story of choice, clinical trials & evidence-based medicine
4. Heart patients benefit from digital image network
5. LEDS Bring Relief to Young Cancer Patients
6. CPM Helps Physicians Group Retain Patients with New Kind of House Call
7. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
8. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
9. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
10. EppendorfPerfect gDNA Blood Mini Kit
11. Higher gDNA Concentrations with the Perfect gDNA Blood Mini Kit by Varying the Final Elution Volume
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014  Atlanta-based Intellimedix could make a positive ... of Ebola by suggesting a new, computational approach ... Center for Computational Systems Biology have spent years ... uses for existing drugs through systematic repurposing, and ... bout against Ebola. Logo - ...
(Date:10/30/2014)... Global polyvinyl chloride (PVC) demand registered a ... 2008-2009, especially in North America and Europe. However, the ... to a growing trend. , The largest chunk of ... construction segment. In 2013, the key PVC application spheres ... rigid film. Moreover, the PVC was consumed in the ...
(Date:10/30/2014)... October 30, 2014 Rancho BioSciences ... they have manually curated public data source TCGA ... customers. the data is now available for other ... unifies public and internal data sources for their Pharma, ... out of the data that becomes more easily accessible. ...
(Date:10/30/2014)... Avure Technologies celebrates a year of success ... of its fleet of high volume High Pressure Processing (HPP) ... we return to PackExpo this year, which is where we ... said Jeff Williams, CEO at Avure. “Sales of the new ... be meeting the challenges of market demand for higher throughput. ...
Breaking Biology Technology:Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3Rancho BioSciences Manually Curated TCGA Data Sets Available 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 2In High Demand: New High Pressure Processing (HPP) System with Maximum Throughput Drives Strong Sales 3
... Jan. 17 Peptimmune, Inc., a privately,held biotechnology ... close,of $8.2 million of a Series D preferred ... Enterprise Associates, MPM Capital, Hunt Ventures,L.P., Boston Medical ... as,certain other investors, including its Chairman of the ...
... at Cleveland Clinic Brings Extensive Experience, in the Use of ... ... Cardiovascular Disease, ST. LOUIS, Jan. 17 Stereotaxis, Inc. ... as Chief Medical Officer. Dr. Burkhardt was most recently the,Associate ...
... ON, Jan. 17 /PRNewswire-FirstCall/ - YM BioSciences Inc.,(AMEX: ... oncology company that identifies,develops and commercializes differentiated products ... a letter from the U.S. Food and Drug,Administration ... Acute Pain,Study (AP5) of AeroLEF(TM) for which FDA ...
Cached Biology Technology:Peptimmune Announces First Close of Series D Private Financing 2Peptimmune Announces First Close of Series D Private Financing 3Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer 2Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer 3YM BioSciences provides update on AeroLEF(TM) clinical development program 2YM BioSciences provides update on AeroLEF(TM) clinical development program 3
(Date:10/30/2014)... 2014 Biological membranes are mainly composed of lipid ... solution ions onto lipid membranes helps clarify functional ... provides a quantitative description of the equilibria between ... and Zbigniew Figaszewski from the University of Bialystok, ... these findings, just published in EPJ E ...
(Date:10/29/2014)... released by unconventional oil and gas production are well ... in the open access journal Environmental Health . ... found. The study is the first to be based ... sites and could be used to supplement official air-quality ... reserves that do not readily flow to the surface. ...
(Date:10/29/2014)... study of its kind to date, researchers have used ... the risk for autism. Joseph Buxbaum, Ph.D., Icahn School ... Daly, Ph.D., Broad Institute of Harvard and MIT, and ... affected children, parents and unrelated people. They identified changes ... the risk for autism spectrum disorder (ASD) – a ...
Breaking Biology News(10 mins):Ion adsorption matter in biology 2Air quality and unconventional oil and gas sites 2Air quality and unconventional oil and gas sites 3
... is hard to fool the brain by providing it with ... driven to a great extent by the amount of energy ... sugars compared to artificial sweeteners. Professor Ivan de Araujo, ... USA, says:,"The consumption of high-calorie beverages is a major contributor ...
... The digestive systems of all animals contain a large number ... provide warmth, shelter and food to a vast range of ... hosts or at least cause no ill effects other than ... have been associated with disease. Among them is Helicobacter ...
... machinery necessary to assemble proteins, the building blocks of ... DNA is first transcribed to messenger RNA in the ... are put in motion to translate the code into ... been demonstrated that the ribosome is far more than ...
Cached Biology News:The brain cannot be fooled by artificial sweeteners 2Getting rid of unwanted visitors 2Global analysis reveals new insights into the ribosome -- with important implications for disease 2Global analysis reveals new insights into the ribosome -- with important implications for disease 3Global analysis reveals new insights into the ribosome -- with important implications for disease 4
... cocktail of 3 siRNAs specifically targeted to ... popular product. The siTrio reagent guarantees you ... target gene when used under standard conditions ... of optimal transfection with one of B-Bridges ...
... This kit #27295 has improved stability and ... improved kit not only has overcome this problem ... first, we have changed the formulation of HRP ... X 1). By this change, the stability of ...
... kit is a complete assay system for ... in human serum or plasma. The assay ... in the IDS 1,25D RIA followed by ... with ready to use reagents, no organic ...
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Biology Products: